Therapeutic approaches to enhance PINK1/Parkin mediated mitophagy for the treatment of Parkinson’s disease
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The discovery of rare familial monogenic forms of early-onset Parkinson's disease has led to the identification of a mitochondrial quality control process as a key player in this disease. Loss-of-function mutations in the genes encoding PINK1 or Parkin result in insufficient removal of dysfunctional mitochondria through autophagy, a process termed mitophagy. Understanding the mechanism of this process and the function of its two key players, PINK1 and Parkin, has led to the discovery of new therapeutic approaches. Small molecule activators of mitophagy, either activating PINK1 or Parkin directly or inhibiting Parkin's counterplayer, the ubiquitin-specific protease USP30, are in preclinical development. To enable clinical success of future small molecule mitophagy enhancers, biomarkers for mitochondrial integrity and mitophagy are being developed. Only a few years after the discovery of mitophagy deficits in Parkinson's disease, research of the underlying mechanisms, drug discovery of modulators for this mechanism and identification of biomarkers provide new avenues towards the development of disease-modifying therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Parkin and PINK1 mitigate STING-induced inflammation
Sliter, D. A., Martinez, J., Hao, L., Chen, X., Sun, N., Fischer, T. D., Burman, J. L., Li, Y., Zhang, Z., Narendra, D. P., et al. (2018) · Nature · doi:10.1038/s41586-018-0448-9 · Cited by 1,287 · cited 5×
“Importantly, components of innate immunity activation are also found in patients with Parkin mutations [104].”
InfluentialRetractedThe protein kinase complement of the human genome
Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002) · Science · doi:10.1126/science.1075762 · Cited by 8,145
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“Discovery of rare familial monogenic forms of PD has provided insights into the pathogenic mechanisms of mitochondrial dysfunction in PD and provided new targets to pursue for drug development [103]: Early-onset autosomal recessive Parkinson’s disease can be caused by mutations in the ubiquitin ligase Parkin and prote…”
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Self-citationPINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
Geisler, S., Holmström, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., & Springer, W. (2010) · Nature Cell Biology · doi:10.1038/ncb2012 · Cited by 2,835 · cited 1×
“Furthermore, conflicting findings have been reported for p62/sequestosome 1 (SQSTM1) as the adaptor for ubiquitinated mitochondria [26,62,75,78,118].”
The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy
Lazarou, M., Sliter, D. A., Kane, L. A., Sarraf, S. A., Wang, C., Burman, J. L., Sideris, D. P., Fogel, A. I., & Youle, R. J. (2015) · Nature · doi:10.1038/nature14893 · Cited by 2,774
The Role of Oxidative Stress in Parkinson's Disease
Dias, V., Junn, E., & Mouradian, M. M. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130230 · Cited by 1,845
Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., Yoo, S. J., Hay, B. A., & Guo, M. (2006) · Nature · doi:10.1038/nature04779 · Cited by 1,788 · cited 1×
“Evidence that the PINK1/Parkin pathway is active in vivo was first provided by studies in Drosophila showing that deficiency of PINK1 or Parkin triggers the accumulation of enlarged, dysfunctional mitochondria in sperm, flight muscle and dopaminergic neurons [10,35,85,120].”
Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin
Park, J., Lee, S. B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim, J.-M., et al. (2006) · Nature · doi:10.1038/nature04788 · Cited by 1,705 · cited 1×
“Evidence that the PINK1/Parkin pathway is active in vivo was first provided by studies in Drosophila showing that deficiency of PINK1 or Parkin triggers the accumulation of enlarged, dysfunctional mitochondria in sperm, flight muscle and dopaminergic neurons [10,35,85,120].”
Bender, A., Krishnan, K. J., Morris, C. M., Taylor, G. A., Reeve, A. K., Perry, R. H., Jaros, E., Hersheson, J. S., Betts, J., Klopstock, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1769 · Cited by 1,570 · cited 1×
“tochondrial dysfunction is central to the disease [39] including the observations that mitochondrial toxins cause parkinsonism in humans and animal models, that PD patients have systemic mitochondrial complex I deficits, and that dopaminergic neurons in elderly individuals accumulate high levels of mitochondrial DNA (…”
Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL
Jin, S. M., Lazarou, M., Wang, C., Kane, L. A., Narendra, D. P., & Youle, R. J. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201008084 · Cited by 1,375
PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity
Kane, L. A., Lazarou, M., Fogel, A. I., Li, Y., Yamano, K., Sarraf, S. A., Banerjee, S., & Youle, R. J. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201402104 · Cited by 1,298
Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants
Greene, J. C., Whitworth, A. J., Kuo, I., Andrews, L. A., Feany, M. B., & Pallanck, L. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737556100 · Cited by 1,203 · cited 1×
“Evidence that the PINK1/Parkin pathway is active in vivo was first provided by studies in Drosophila showing that deficiency of PINK1 or Parkin triggers the accumulation of enlarged, dysfunctional mitochondria in sperm, flight muscle and dopaminergic neurons [10,35,85,120].”
Kondapalli, C., Kazlauskaite, A., Zhang, N., Woodroof, H. I., Campbell, D. G., Gourlay, R., Burchell, L., Walden, H., Macartney, T. J., Deak, M., et al. (2012) · Open Biology · doi:10.1098/rsob.120080 · Cited by 940
Self-citationParkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308947200 · Cited by 913 · cited 1×
“However, KO mice lacking PINK1 or Parkin genes show subtle behavioral and neurochemical abnormalities and no overt dopaminergic neuron degeneration [2,31,34,51,86] and therefore have been unable to address the contribution of PINK1 and Parkin to stress-evoked mitophagy in vivo.”
Heo, J.-M., Ordureau, A., Paulo, J. A., Rinehart, J., & Harper, J. W. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.08.016 · Cited by 906
The mitochondrial deubiquitinase USP30 opposes parkin-mediated mitophagy
Bingol, B., Tea, J. S., Phu, L., Reichelt, M., Bakalarski, C. E., Song, Q., Foreman, O., Kirkpatrick, D. S., & Sheng, M. (2014) · Nature · doi:10.1038/nature13418 · Cited by 855 · cited 5×
“phagy in human cell lines overexpressing Parkin and rescues parkinsonian phenotypes in Drosophila expressing PINK1 or Parkin mutations [6].”
InfluentialWong, Y. C., & Holzbaur, E. L. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405752111 · Cited by 812 · cited 2×
“Furthermore, conflicting findings have been reported for p62/sequestosome 1 (SQSTM1) as the adaptor for ubiquitinated mitochondria [26,62,75,78,118].”
Parkin is activated by PINK1-dependent phosphorylation of ubiquitin at Ser65
Kazlauskaite, A., Kondapalli, C., Gourlay, R., Campbell, D. G., Ritorto, M. S., Hofmann, K., Alessi, D. R., Knebel, A., Trost, M., & Muqit, M. M. K. (2014) · Biochemical Journal · doi:10.1042/bj20140334 · Cited by 806 · cited 1×
“However, in response to mitochondrial membrane depolarisation, PINK1 [111] is not cleaved and accumulates on the outer membrane of mitochondria where it phosphorylates ubiquitin on outer mitochondrial membrane (OMM) proteins at Serine 65 (Ser65) [48,49,55].”
Self-citationYang, Y., Gehrke, S., Imai, Y., Huang, Z., Ouyang, Y., Wang, J.-W., Yang, L., Beal, M. F., Vogel, H., & Lu, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602493103 · Cited by 798
Lazarou, M., Jin, S. M., Kane, L. A., & Youle, R. J. (2012) · Developmental Cell · doi:10.1016/j.devcel.2011.12.014 · Cited by 670
Basal Mitophagy Occurs Independently of PINK1 in Mouse Tissues of High Metabolic Demand
McWilliams, T. G., Prescott, A. R., Montava-Garriga, L., Ball, G., Singh, F., Barini, E., Muqit, M. M. K., Brooks, S. P., & Ganley, I. G. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.12.008 · Cited by 591
Self-citationParkinson’s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation
Matheoud, D., Sugiura, A., Bellemare-Pelletier, A., Laplante, A., Rondeau, C., Chemali, M., Fazel, A., Bergeron, J. J., Trudeau, L.-E., Burelle, Y., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.039 · Cited by 582 · cited 1×
“Supporting a role for PINK1 and Parkin in immune responses, PINK1 and Parkin were shown to mediate mitochondrial antigen presentation and trigger adaptive immune responses in a mouse macrophage cell line through mitochondrial-derived vesicles [69].”
The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo
Vincow, E. S., Merrihew, G., Thomas, R. E., Shulman, N. J., Beyer, R. P., MacCoss, M. J., & Pallanck, L. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221132110 · Cited by 478 · cited 1×
“Moreover, a proteomics approach revealed that the half-life of several mitochondrial proteins was increased in Parkin mutant flies in a pattern similar to that of autophagy-defective Atg7 mutants, thus supporting a role for Parkin in mitophagy [113].”
Parkin-deficient mice are not a robust model of parkinsonism
Perez, F. A., & Palmiter, R. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409598102 · Cited by 477 · cited 1×
“However, KO mice lacking PINK1 or Parkin genes show subtle behavioral and neurochemical abnormalities and no overt dopaminergic neuron degeneration [2,31,34,51,86] and therefore have been unable to address the contribution of PINK1 and Parkin to stress-evoked mitophagy in vivo.”
p62/SQSTM1 cooperates with Parkin for perinuclear clustering of depolarized mitochondria
Okatsu, K., Saisho, K., Shimanuki, M., Nakada, K., Shitara, H., Sou, Y., Kimura, M., Sato, S., Hattori, N., Komatsu, M., et al. (2010) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01426.x · Cited by 397 · cited 1×
“Furthermore, conflicting findings have been reported for p62/sequestosome 1 (SQSTM1) as the adaptor for ubiquitinated mitochondria [26,62,75,78,118].”
USP8 regulates mitophagy by removing K6‐linked ubiquitin conjugates from parkin
Durcan, T. M., Tang, M. Y., Pérusse, J. R., Dashti, E. A., Aguileta, M. A., McLelland, G., Gros, P., Shaler, T. A., Faubert, D., Coulombe, B., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201489729 · Cited by 375 · cited 1×
“Another DUB, USP8, was shown to activate mitophagy by removing ubiquitin residues from Parkin and preventing its auto-inhibition [21].”
Targeting Mitochondrial Dysfunction: Role for PINK1 and Parkin in Mitochondrial Quality Control
Narendra, D. P., & Youle, R. J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3799 · Cited by 367 · cited 1×
“Discovery of rare familial monogenic forms of PD has provided insights into the pathogenic mechanisms of mitochondrial dysfunction in PD and provided new targets to pursue for drug development [103]: Early-onset autosomal recessive Parkinson’s disease can be caused by mutations in the ubiquitin ligase Parkin and prote…”
High-content genome-wide RNAi screens identify regulators of parkin upstream of mitophagy
Hasson, S. A., Kane, L. A., Yamano, K., Huang, C.-H., Sliter, D. A., Buehler, E., Wang, C., Heman-Ackah, S. M., Hessa, T., Guha, R., et al. (2013) · Nature · doi:10.1038/nature12748 · Cited by 365 · cited 2×
“those with an intact membrane potential, PINK1 is imported into mitochondria and subsequently cleaved by the protease, presenilins-associated rhomboid-like protein (PARL) [47], leading to its degradation via the N-end rule pathway [38].”
Autoregulation of Parkin activity through its ubiquitin‐like domain
Chaugule, V. K., Burchell, L., Barber, K. R., Sidhu, A., Leslie, S. J., Shaw, G. S., & Walden, H. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.204 · Cited by 339 · cited 2×
“Structures of Parkin show that under basal conditions it adopts an autoinhibited conformation mediated by its N-terminal Ubl domain through three mechanisms [8,57,109]: First, the RING0 domain partially occludes the catalytic cysteine (Cys431).”
A neo-substrate that amplifies catalytic activity of Parkinson's-disease-related kinase PINK1
Hertz, N. T., Berthet, A., Sos, M. L., Thorn, K. S., Burlingame, A. L., Nakamura, K., & Shokat, K. M. (2013) · Cell · doi:10.1016/j.cell.2013.07.030 · Cited by 275
Jiang, H., Ren, Y., Yuen, E. Y., Zhong, P., Ghaedi, M., Hu, Z., Azabdaftari, G., Nakaso, K., Yan, Z., & Feng, J. (2012) · Nature Communications · doi:10.1038/ncomms1669 · Cited by 254 · cited 1×
“Relatively modest morphological or functional changes in mitochondria have been observed in iPSC-derived neurons with PINK1 [72,93,99] or Parkin mutations [9,43,46,100] and analysis of mitophagy in these neuronal systems using either mt-Keima”
Rakovic, A., Shurkewitsch, K., Seibler, P., Grünewald, A., Zanon, A., Hagenah, J., Krainc, D., & Klein, C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.391680 · Cited by 218
Blanch, M., Mosquera, J. L., Ansoleaga, B., Ferrer, I., & Barrachina, M. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.10.004 · Cited by 192 · cited 1×
“In postmortem PD brains, the D-loop region of mtDNA, which is important for mitochondrial transcription and replication, showed a loss of methylation in nearly all CpG and non-CpG sites relative to control samples [7], but further research is necessary to confirm concordance between blood and brain [45].”
(Patho‐)physiological relevance of PINK1‐dependent ubiquitin phosphorylation
Fiesel, F. C., Ando, M., Hudec, R., Hill, A. R., Castanedes‐Casey, M., Caulfield, T. R., Moussaud‐Lamodière, E. L., Stankowski, J. N., Bauer, P. O., Lorenzo‐Betancor, O., et al. (2015) · The EMBO Reports · doi:10.15252/embr.201540514 · Cited by 185 · cited 3×
“As a direct measure of PINK1 and Parkin activity, pS65-Ub is a promising biomarker [23,27].”
BackgroundDual role of USP30 in controlling basal pexophagy and mitophagy
Marcassa, E., Kallinos, A., Jardine, J., Rusilowicz‐Jones, E. V., Martinez, A., Kuehl, S., Islinger, M., Clague, M. J., & Urbé, S. (2018) · The EMBO Reports · doi:10.15252/embr.201745595 · Cited by 158 · cited 4×
“Using both, mtKeima and mitoQC reporter systems it was shown in cells in vitro that depletion of USP30 increases mitophagy, but not in the absence of PINK1 [67].”
InfluentialPINK1 function in health and disease
Deas, E., Plun‐Favreau, H., & Wood, N. W. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900024 · Cited by 154 · cited 1×
“30 missense and nonsense human PINK1 (hPINK1) mutations have been reported in patients [17] that are located predominantly within the kinase domain or predicted to truncate the C-terminal region [33,58,79].”
Ivatt, R. M., Sanchez-Martinez, A., Godena, V. K., Brown, S., Ziviani, E., & Whitworth, A. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321207111 · Cited by 130 · cited 1×
“A similar siRNA screening paradigm in Drosophila cells discovered several targets in the sterol regulatory element binding transcription factor (SREBF) lipogenesis pathway and showed that exogenous lipids can promote mitophagy [44].”
Crosstalk between Lysosomes and Mitochondria in Parkinson's Disease
Plotegher, N., & Duchen, M. R. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00110 · Cited by 106
Potting, C., Crochemore, C., Moretti, F., Nigsch, F., Schmidt, I., Manneville, C., Carbone, W., Knehr, J., DeJesus, R., Lindeman, A., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711023115 · Cited by 93
Gui, Y.-X., Xu, Z.-P., Lv, W., Zhao, J.-J., & Hu, X.-Y. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.12.030 · Cited by 59
Cited by
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Guo, J., Huang, X., Dou, L., Yan, M., Shen, T., Tang, W., & Li, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01251-0 · Cited by 1,718
Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities
Schmidt, M. F., Gan, Z. Y., Komander, D., & Dewson, G. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-020-00706-7 · Cited by 368
Dewson, G., Eichhorn, P. J. A., & Komander, D. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00633-y · Cited by 326
Mitochondrial quality control in health and in Parkinson’s disease
Eldeeb, M. A., Thomas, R. A., Ragheb, M. A., Fallahi, A., & Fon, E. A. (2022) · Physiological Reviews · doi:10.1152/physrev.00041.2021 · Cited by 265
Wallings, R. L., Humble, S. W., Ward, M. E., & Wade-Martins, R. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.10.002 · Cited by 153
Metadata
- Authors
- Miller, S., & Muqit, M. M. K.
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2019-07
- Volume
- 705
- Pages
- 7-13
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2936115703
- Cited by
- 129
- References
- 41
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.